{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 5,
        "Importance": 6,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 6,
        "Specificity": 7,
        "Sector_Spread": 5,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "BIG #Microcap #Breakout Coming To $PVSP! Far Easier Than $MSFT $PFE $BBRY",
            "Correlation": 4,
            "Sentiment": 8,
            "Importance": 3,
            "Impact": 4,
            "Duration": 2,
            "Virality": 5,
            "Source_Score": 3,
            "Specificity": 5,
            "Sector_Spread": 1,
            "Tech_Mentions": 0
        },
        {
            "News_content": "Earnings before the bell: $APD $AKS $CHKP $CIT $CMCSA $GLW $DHI $DD $F $ITW $MNRO $NUE $OSK $PFE $PII $TROW",
            "Correlation": 9,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 9,
            "Tech_Mentions": 1
        },
        {
            "News_content": "@MarkSchoenebaum That's new info. What are the criteria for such an action? $PFE",
            "Correlation": 6,
            "Sentiment": 4,
            "Importance": 5,
            "Impact": 5,
            "Duration": 3,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 6,
            "Sector_Spread": 2,
            "Tech_Mentions": 0
        },
        {
            "News_content": ".@jonathanrockoff During CCs, analysts from IBs are relentless in pursuing their self-interest from a pot $PFE split-up.",
            "Correlation": 7,
            "Sentiment": 3,
            "Importance": 6,
            "Impact": 6,
            "Duration": 4,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 3,
            "Tech_Mentions": 0
        },
        {
            "News_content": "Pfizer reports non-GAAP profit of 56 cents a share, better than expected. Sales fell 2% to $13.56 billion. $PFE",
            "Correlation": 10,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 8,
            "Duration": 5,
            "Virality": 6,
            "Source_Score": 9,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        }
    ]
}